Fariborz Shams, Do Inc. - Medicare Primary Care in Anaheim, CA

Fariborz Shams, Do Inc. is a medicare enrolled primary clinic (Internal Medicine) in Anaheim, California. The current practice location for Fariborz Shams, Do Inc. is 515 S Beach Blvd Ste F, Anaheim, California. For appointments, you can reach them via phone at (714) 995-7503. The mailing address for Fariborz Shams, Do Inc. is 515 S Beach Blvd Ste F, Anaheim, California and phone number is (714) 995-7503.

Fariborz Shams, Do Inc. is licensed to practice in California (license number 20A6510). The clinic also participates in the medicare program and its NPI number is 1215107495. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (714) 995-7503.

Contact Information

Fariborz Shams, Do Inc.
515 S Beach Blvd Ste F
Anaheim
CA 92804-1812
(714) 995-7503
Not Available

Primary Care Clinic Profile

Full NameFariborz Shams, Do Inc.
SpecialityInternal Medicine
Location515 S Beach Blvd Ste F, Anaheim, California
Authorized Official Name and PositionFariborz Shams (PHYSICIAN/OWNER)
Authorized Official Contact7149957503
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Fariborz Shams, Do Inc.
515 S Beach Blvd Ste F
Anaheim
CA 92804-1812

Ph: (714) 995-7503
Fariborz Shams, Do Inc.
515 S Beach Blvd Ste F
Anaheim
CA 92804-1812

Ph: (714) 995-7503

NPI Details:

NPI Number1215107495
Provider Enumeration Date03/04/2008
Last Update Date02/23/2012

Medicare PECOS Information:

Medicare PECOS PAC ID9739267709
Medicare Enrollment IDO20080416000679

News Archive

Breast milk component induces expression of P-glycoprotein

Researchers at Children's Hospital Los Angeles have found that a component of breast milk induces expression of P-glycoprotein (Pgp), a protein that is protective against necrotizing enterocolitis (NEC)-a complex, lethal disease that affects up to 7 percent of babies admitted to the NICU.

NinePoint announces completion of $33 million Series A financing

NinePoint Medical, Inc., an emerging leader in the development of in vivo pathology devices, today announced it has completed a $33 million Series A financing led by Third Rock Ventures and Prospect Venture Partners. The company also announced the establishment of its corporate headquarters in Cambridge, Mass. where Charles Carignan, M.D., serves as president and chief executive officer.

Tioga Pharmaceuticals announces commencement of asimadoline Phase 2 study for treatment of pruritus

Tioga Pharmaceuticals, a clinical stage biotechnology company, today announced the initiation of a Phase 2 clinical study of asimadoline, a novel, well-studied kappa-opioid receptor specific agonist, for the treatment of pruritus or itching. The double-blind, placebo-controlled clinical study is designed to evaluate the safety, tolerability, and clinical efficacy of asimadoline in patients with pruritus due to atopic dermatitis and is being conducted at 20 clinical study centers in the United States.

New technique could give a preview of which eggs are likely to make the most viable embryos

Given the stakes of in vitro fertilization, prospective parents and their doctors need the best information they can get about the eggs they will extract, attempt to fertilize, and implant. New research at Brown University and Women & Infants Hospital of Rhode Island has found a way to see which genes each egg cell is expressing without harming it.

CDC reports slight drop in smoking; tick worries blood experts

Fewer American adults are smoking cigarettes, and those who do are smoking less, the Centers for Disease Control and Prevention reported on Tuesday. The CDC's latest data from 2010 show that an estimated 19.3 percent of American adults, or 45.3 million people, smoke. This is a slight decline from 20.9 percent in 2005. Of those adults who smoke, the new data show, 78.2 percent - or 35.4 million - do so every day.

Read more Medical News

› Verified 9 days ago

Medical Identifiers

Medical identifiers for Fariborz Shams, Do Inc. such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1215107495NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207R00000XInternal Medicine 20A6510 (California)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Fariborz Shams, Do Inc. acts as a billing entity for following providers:
Provider NameSelma Prechel
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1629252176
PECOS PAC ID: 1850479791
Enrollment ID: I20080417000596

News Archive

Breast milk component induces expression of P-glycoprotein

Researchers at Children's Hospital Los Angeles have found that a component of breast milk induces expression of P-glycoprotein (Pgp), a protein that is protective against necrotizing enterocolitis (NEC)-a complex, lethal disease that affects up to 7 percent of babies admitted to the NICU.

NinePoint announces completion of $33 million Series A financing

NinePoint Medical, Inc., an emerging leader in the development of in vivo pathology devices, today announced it has completed a $33 million Series A financing led by Third Rock Ventures and Prospect Venture Partners. The company also announced the establishment of its corporate headquarters in Cambridge, Mass. where Charles Carignan, M.D., serves as president and chief executive officer.

Tioga Pharmaceuticals announces commencement of asimadoline Phase 2 study for treatment of pruritus

Tioga Pharmaceuticals, a clinical stage biotechnology company, today announced the initiation of a Phase 2 clinical study of asimadoline, a novel, well-studied kappa-opioid receptor specific agonist, for the treatment of pruritus or itching. The double-blind, placebo-controlled clinical study is designed to evaluate the safety, tolerability, and clinical efficacy of asimadoline in patients with pruritus due to atopic dermatitis and is being conducted at 20 clinical study centers in the United States.

New technique could give a preview of which eggs are likely to make the most viable embryos

Given the stakes of in vitro fertilization, prospective parents and their doctors need the best information they can get about the eggs they will extract, attempt to fertilize, and implant. New research at Brown University and Women & Infants Hospital of Rhode Island has found a way to see which genes each egg cell is expressing without harming it.

CDC reports slight drop in smoking; tick worries blood experts

Fewer American adults are smoking cigarettes, and those who do are smoking less, the Centers for Disease Control and Prevention reported on Tuesday. The CDC's latest data from 2010 show that an estimated 19.3 percent of American adults, or 45.3 million people, smoke. This is a slight decline from 20.9 percent in 2005. Of those adults who smoke, the new data show, 78.2 percent - or 35.4 million - do so every day.

Read more Medical News

› Verified 9 days ago

Provider NameFariborz Shams
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1063421865
PECOS PAC ID: 1557449527
Enrollment ID: I20100830000943

News Archive

Breast milk component induces expression of P-glycoprotein

Researchers at Children's Hospital Los Angeles have found that a component of breast milk induces expression of P-glycoprotein (Pgp), a protein that is protective against necrotizing enterocolitis (NEC)-a complex, lethal disease that affects up to 7 percent of babies admitted to the NICU.

NinePoint announces completion of $33 million Series A financing

NinePoint Medical, Inc., an emerging leader in the development of in vivo pathology devices, today announced it has completed a $33 million Series A financing led by Third Rock Ventures and Prospect Venture Partners. The company also announced the establishment of its corporate headquarters in Cambridge, Mass. where Charles Carignan, M.D., serves as president and chief executive officer.

Tioga Pharmaceuticals announces commencement of asimadoline Phase 2 study for treatment of pruritus

Tioga Pharmaceuticals, a clinical stage biotechnology company, today announced the initiation of a Phase 2 clinical study of asimadoline, a novel, well-studied kappa-opioid receptor specific agonist, for the treatment of pruritus or itching. The double-blind, placebo-controlled clinical study is designed to evaluate the safety, tolerability, and clinical efficacy of asimadoline in patients with pruritus due to atopic dermatitis and is being conducted at 20 clinical study centers in the United States.

New technique could give a preview of which eggs are likely to make the most viable embryos

Given the stakes of in vitro fertilization, prospective parents and their doctors need the best information they can get about the eggs they will extract, attempt to fertilize, and implant. New research at Brown University and Women & Infants Hospital of Rhode Island has found a way to see which genes each egg cell is expressing without harming it.

CDC reports slight drop in smoking; tick worries blood experts

Fewer American adults are smoking cigarettes, and those who do are smoking less, the Centers for Disease Control and Prevention reported on Tuesday. The CDC's latest data from 2010 show that an estimated 19.3 percent of American adults, or 45.3 million people, smoke. This is a slight decline from 20.9 percent in 2005. Of those adults who smoke, the new data show, 78.2 percent - or 35.4 million - do so every day.

Read more Medical News

› Verified 9 days ago

Provider NameErika Cruz
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1477946747
PECOS PAC ID: 3173841830
Enrollment ID: I20150409002495

News Archive

Breast milk component induces expression of P-glycoprotein

Researchers at Children's Hospital Los Angeles have found that a component of breast milk induces expression of P-glycoprotein (Pgp), a protein that is protective against necrotizing enterocolitis (NEC)-a complex, lethal disease that affects up to 7 percent of babies admitted to the NICU.

NinePoint announces completion of $33 million Series A financing

NinePoint Medical, Inc., an emerging leader in the development of in vivo pathology devices, today announced it has completed a $33 million Series A financing led by Third Rock Ventures and Prospect Venture Partners. The company also announced the establishment of its corporate headquarters in Cambridge, Mass. where Charles Carignan, M.D., serves as president and chief executive officer.

Tioga Pharmaceuticals announces commencement of asimadoline Phase 2 study for treatment of pruritus

Tioga Pharmaceuticals, a clinical stage biotechnology company, today announced the initiation of a Phase 2 clinical study of asimadoline, a novel, well-studied kappa-opioid receptor specific agonist, for the treatment of pruritus or itching. The double-blind, placebo-controlled clinical study is designed to evaluate the safety, tolerability, and clinical efficacy of asimadoline in patients with pruritus due to atopic dermatitis and is being conducted at 20 clinical study centers in the United States.

New technique could give a preview of which eggs are likely to make the most viable embryos

Given the stakes of in vitro fertilization, prospective parents and their doctors need the best information they can get about the eggs they will extract, attempt to fertilize, and implant. New research at Brown University and Women & Infants Hospital of Rhode Island has found a way to see which genes each egg cell is expressing without harming it.

CDC reports slight drop in smoking; tick worries blood experts

Fewer American adults are smoking cigarettes, and those who do are smoking less, the Centers for Disease Control and Prevention reported on Tuesday. The CDC's latest data from 2010 show that an estimated 19.3 percent of American adults, or 45.3 million people, smoke. This is a slight decline from 20.9 percent in 2005. Of those adults who smoke, the new data show, 78.2 percent - or 35.4 million - do so every day.

Read more Medical News

› Verified 9 days ago

Provider NameKaren J Caruso
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1679816680
PECOS PAC ID: 0648572297
Enrollment ID: I20160113002149

News Archive

Breast milk component induces expression of P-glycoprotein

Researchers at Children's Hospital Los Angeles have found that a component of breast milk induces expression of P-glycoprotein (Pgp), a protein that is protective against necrotizing enterocolitis (NEC)-a complex, lethal disease that affects up to 7 percent of babies admitted to the NICU.

NinePoint announces completion of $33 million Series A financing

NinePoint Medical, Inc., an emerging leader in the development of in vivo pathology devices, today announced it has completed a $33 million Series A financing led by Third Rock Ventures and Prospect Venture Partners. The company also announced the establishment of its corporate headquarters in Cambridge, Mass. where Charles Carignan, M.D., serves as president and chief executive officer.

Tioga Pharmaceuticals announces commencement of asimadoline Phase 2 study for treatment of pruritus

Tioga Pharmaceuticals, a clinical stage biotechnology company, today announced the initiation of a Phase 2 clinical study of asimadoline, a novel, well-studied kappa-opioid receptor specific agonist, for the treatment of pruritus or itching. The double-blind, placebo-controlled clinical study is designed to evaluate the safety, tolerability, and clinical efficacy of asimadoline in patients with pruritus due to atopic dermatitis and is being conducted at 20 clinical study centers in the United States.

New technique could give a preview of which eggs are likely to make the most viable embryos

Given the stakes of in vitro fertilization, prospective parents and their doctors need the best information they can get about the eggs they will extract, attempt to fertilize, and implant. New research at Brown University and Women & Infants Hospital of Rhode Island has found a way to see which genes each egg cell is expressing without harming it.

CDC reports slight drop in smoking; tick worries blood experts

Fewer American adults are smoking cigarettes, and those who do are smoking less, the Centers for Disease Control and Prevention reported on Tuesday. The CDC's latest data from 2010 show that an estimated 19.3 percent of American adults, or 45.3 million people, smoke. This is a slight decline from 20.9 percent in 2005. Of those adults who smoke, the new data show, 78.2 percent - or 35.4 million - do so every day.

Read more Medical News

› Verified 9 days ago

Provider NameLucia Young
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1518227917
PECOS PAC ID: 1153607254
Enrollment ID: I20170403002381

News Archive

Breast milk component induces expression of P-glycoprotein

Researchers at Children's Hospital Los Angeles have found that a component of breast milk induces expression of P-glycoprotein (Pgp), a protein that is protective against necrotizing enterocolitis (NEC)-a complex, lethal disease that affects up to 7 percent of babies admitted to the NICU.

NinePoint announces completion of $33 million Series A financing

NinePoint Medical, Inc., an emerging leader in the development of in vivo pathology devices, today announced it has completed a $33 million Series A financing led by Third Rock Ventures and Prospect Venture Partners. The company also announced the establishment of its corporate headquarters in Cambridge, Mass. where Charles Carignan, M.D., serves as president and chief executive officer.

Tioga Pharmaceuticals announces commencement of asimadoline Phase 2 study for treatment of pruritus

Tioga Pharmaceuticals, a clinical stage biotechnology company, today announced the initiation of a Phase 2 clinical study of asimadoline, a novel, well-studied kappa-opioid receptor specific agonist, for the treatment of pruritus or itching. The double-blind, placebo-controlled clinical study is designed to evaluate the safety, tolerability, and clinical efficacy of asimadoline in patients with pruritus due to atopic dermatitis and is being conducted at 20 clinical study centers in the United States.

New technique could give a preview of which eggs are likely to make the most viable embryos

Given the stakes of in vitro fertilization, prospective parents and their doctors need the best information they can get about the eggs they will extract, attempt to fertilize, and implant. New research at Brown University and Women & Infants Hospital of Rhode Island has found a way to see which genes each egg cell is expressing without harming it.

CDC reports slight drop in smoking; tick worries blood experts

Fewer American adults are smoking cigarettes, and those who do are smoking less, the Centers for Disease Control and Prevention reported on Tuesday. The CDC's latest data from 2010 show that an estimated 19.3 percent of American adults, or 45.3 million people, smoke. This is a slight decline from 20.9 percent in 2005. Of those adults who smoke, the new data show, 78.2 percent - or 35.4 million - do so every day.

Read more Medical News

› Verified 9 days ago

News Archive

Breast milk component induces expression of P-glycoprotein

Researchers at Children's Hospital Los Angeles have found that a component of breast milk induces expression of P-glycoprotein (Pgp), a protein that is protective against necrotizing enterocolitis (NEC)-a complex, lethal disease that affects up to 7 percent of babies admitted to the NICU.

NinePoint announces completion of $33 million Series A financing

NinePoint Medical, Inc., an emerging leader in the development of in vivo pathology devices, today announced it has completed a $33 million Series A financing led by Third Rock Ventures and Prospect Venture Partners. The company also announced the establishment of its corporate headquarters in Cambridge, Mass. where Charles Carignan, M.D., serves as president and chief executive officer.

Tioga Pharmaceuticals announces commencement of asimadoline Phase 2 study for treatment of pruritus

Tioga Pharmaceuticals, a clinical stage biotechnology company, today announced the initiation of a Phase 2 clinical study of asimadoline, a novel, well-studied kappa-opioid receptor specific agonist, for the treatment of pruritus or itching. The double-blind, placebo-controlled clinical study is designed to evaluate the safety, tolerability, and clinical efficacy of asimadoline in patients with pruritus due to atopic dermatitis and is being conducted at 20 clinical study centers in the United States.

New technique could give a preview of which eggs are likely to make the most viable embryos

Given the stakes of in vitro fertilization, prospective parents and their doctors need the best information they can get about the eggs they will extract, attempt to fertilize, and implant. New research at Brown University and Women & Infants Hospital of Rhode Island has found a way to see which genes each egg cell is expressing without harming it.

CDC reports slight drop in smoking; tick worries blood experts

Fewer American adults are smoking cigarettes, and those who do are smoking less, the Centers for Disease Control and Prevention reported on Tuesday. The CDC's latest data from 2010 show that an estimated 19.3 percent of American adults, or 45.3 million people, smoke. This is a slight decline from 20.9 percent in 2005. Of those adults who smoke, the new data show, 78.2 percent - or 35.4 million - do so every day.

Read more News

› Verified 9 days ago


Internal Medicine in Anaheim, CA

The Family Medicine Center
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1211 W. La Palma Avenue, Suite #404, Anaheim, CA 92801
Phone: 714-772-1030    Fax: 714-772-1758
Anaheim Medical Group Inc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 2571 W La Palma Ave, Anaheim, CA 92801
Phone: 714-827-9797    Fax: 714-827-5377
Shirdi Medical Corporation
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1751 W Romneya Dr, Anaheim, CA 92801
Phone: 714-776-3180    Fax: 714-991-1932
Rakesh Kumar Bhola ,m.d. Inc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 1781 W Romneya Dr Ste C, Anaheim, CA 92801
Phone: 714-776-2700    
Anaheim Health Care Center
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1125 N Magnolia Ave, Anaheim, CA 92801
Phone: 714-484-1280    Fax: 714-484-1358
Richard Dick M Yip Md A Medical Corp
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 408 S Beach Blvd Ste 211, Anaheim, CA 92804
Phone: 714-527-6000    Fax: 714-527-2371
Benevolence Health Center
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 303 N East St, Anaheim, CA 92805
Phone: 714-491-1771    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.